Cargando…
Neonatal iron supplementation potentiates oxidative stress, energetic dysfunction and neurodegeneration in the R6/2 mouse model of Huntington's disease
Huntington’s disease (HD) is a progressive neurodegenerative disorder caused by a CAG repeat expansion that encodes a polyglutamine tract in huntingtin (htt) protein. Dysregulation of brain iron homeostasis, oxidative stress and neurodegeneration are consistent features of the HD phenotype. Therefor...
Autores principales: | Berggren, Kiersten L., Chen, Jianfang, Fox, Julia, Miller, Jonathan, Dodds, Lindsay, Dugas, Bryan, Vargas, Liset, Lothian, Amber, McAllum, Erin, Volitakis, Irene, Roberts, Blaine, Bush, Ashley I., Fox, Jonathan H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348428/ https://www.ncbi.nlm.nih.gov/pubmed/25703232 http://dx.doi.org/10.1016/j.redox.2015.02.002 |
Ejemplares similares
-
Characterization of Striatal Neuronal Loss and Atrophy in the R6/2 Mouse Model of Huntington’s Disease
por: Dodds, Lindsay, et al.
Publicado: (2014) -
Iron Accumulates in Huntington’s Disease Neurons: Protection by Deferoxamine
por: Chen, Jianfang, et al.
Publicado: (2013) -
Correction: Iron Accumulates in Huntington’s Disease Neurons: Protection by Deferoxamine
por: Chen, Jianfang, et al.
Publicado: (2013) -
Metalloproteomics: principles, challenges and applications to neurodegeneration
por: Lothian, Amber, et al.
Publicado: (2013) -
Neonatal Iron Supplementation Induces Striatal Atrophy in Female YAC128 Huntington’s Disease Mice
por: Berggren, Kiersten L., et al.
Publicado: (2016)